英文名:cyclo(RGDFK(DOTA)),
DOTA-c(RGDfK),
DOTA-cyclo(RGDfK)
CAS:N/A
分子式:C43H67N13O14
分子量:989.09
结构式:
反应机理:
DOTA-cyclo(RGDfK)螯合剂多肽,RGD肽是指含有由Arg-Gly-Asp三个氨基酸组成的序列多肽,有直线肽和环肽之分。其中RGD作为某些整合素的受体,其选择性部分依赖于RGD的构象以及RGD周围的氨基酸残基。DOTA 中的四个氮原子和以及氮原子上乙酸中的羧基可与金属配位,是一类常用的双功能螯合剂。
它们是许多细胞外基质蛋白(如VN、FN、FGN、胶原等)等小识别短肽序列。RGD作为某些整合素的受体,其选择性部分依赖于RGD的构象以及RGD周围的氨基酸残基。
DOTA cycle (RGDfK) chelating agent peptide, RGD peptide refers to a sequence peptide composed of Arg Gly Asp three amino acids, which can be divided into linear peptide and cyclic peptide. They are small recognition short peptide sequences of many extracellular matrix proteins (such as VN, FN, FGN, collagen, etc.). As a receptor for certain integrins, the selectivity of RGD partially depends on the conformation of RGD and the amino acid residues around RGD.
(上述信息均由陕西新研博美生物科技有限公司的小编木木所整理)
产品形式:
1.外观为固体/粉末
2.溶于大部分有机溶剂,溶于水
3.纯度标准95+,详情可在线咨询
保存建议:避免反复冻融,避光避湿保存,储液应该立即使用,-20℃以下冰冻。从冰箱取出产品后,置于室温回温至少30min-1h,再开盖,以避免受潮。
同类型试剂:
Fmoc-Thr(Ac3GalNAcα)-OH
Fmoc-Thr(Ac4Galβ1-3Ac2GalNAcα)-OH
Fmoc-Thr(Me,Ac4Neu5Acα2-6Ac2GalNAcα)-OH
Fmoc-Thr(Ac4Manα1-2Ac3Manα1-2Ac3Manα)-OH
Fmoc-Thr((Ac4Galβ1-3)Me,Ac4Neu5Acα2-6AcGalNAcα)-OH
Fmoc-Thr((Ac4Galβ1-3)Ac3GlcNAcβ1-6AcGalNAcα)-OH
Fmoc-Thr(Ac4Manα)-OH
Fmoc-Thr(Ac4Manα1-2Ac3Manα)-OH
Fmoc-L-Thr(Ac4-D-Glcβ)-OH
cyclo(RGDFK(DOTA))
Cyclo[(D-Tyr)-(D-NMe-Orn)-Arg-(2-Nal)-Gly] [Cyclo(D-Tyr)
Cyclo(-Hyp-Gly)
CTTHWGFTLC, CYCLIC
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid(ACI)
(R)-tert-Bu4-DOTAGA
FAPI-4-NH2
PSMA I&T,DOTAGA-DTyr(3I)-DPhe-DLys(Sub-Lys-urea-Glu)
DOTA-E-[cyclo(RGDfK(Acp))]2
DOTA-cyclo(RGDfK) acetate
DOTA-cyclo(RGDyK)
DOTA-cyclo(RGDfK)
DOTA-E[c(RGDyK)2]
DOTA-PEG5-DBCO
DOTA-PEG5-azide
注意点:仅用于科学研究或者工业应用等非医疗目的,不可用于人类,非药用,非食用